Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine Ophthalmic Solution in Allergic Conjunctivitis
NCT03231969Phase 2Completed
- Sponsor
- Faes Farma
- Start
- Jul 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bilastine in allergic conjunctivitis (AC), sponsored by Faes Farma. Started Jul 2017; status: completed.
02
Drugs
bilastine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT03231969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03231969.